Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
FID-007 for Head and Neck Squamous Cell Carcinoma
Recruiting1 awardPhase 2
Canton, Ohio
This trial aims to test different ways of giving FID-007 along with Cetuximab to patients with recurrent or metastatic Head and Neck Squamous Cell Carcinoma. They want to
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.